Global Adaptive Self Injection Systems market 2017-2024: Analysis of More than Two Dozen Adaptive Devices Currently Being Marketed for Patient Use
Comunicato Precedente
Comunicato Successivo
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector.
The injectable drug segment has seen a marked increase in the level of drug/device integration, as specialty syringes and specialized injection devices proliferate in response to safety and formulation challenges posed by new and emerging drugs, and as the administration of injectables moves increasingly from practitioner offices and healthcare facilities to patient homes.
In response to these market dynamics, device suppliers are introducing injection systems that possess new capabilities and which can adapt to the evolving needs of drug developers and patients. This report analyzes more than two dozen adaptive devices currently being marketed for patient use.
What You Will Learn
Key Topics Covered:
1. Executive Summary
2. Injectable Device Evolution
3. Device Design Factors
4. Injectable Drug Market Dynamics
5. Self-Administration Device Classes
6. Adaptable Injectors - Feature Sets
7. Adaptable Injection System Product - Assessments & Market Data
8. Therapeutic Segment Alignment, Use Cases & Product Forecasts
9. Market Factors
10. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/kwtfxg/global_adaptive?w=5
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
